ReviewCurrent opinion in HIV and AIDS2015
Geographical targeting to improve progression through the sexually transmitted infection/HIV treatment continua in different populations.
Review in Current opinion in HIV and AIDS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Evaluating spatially targeted HIV interventions and harm reduction services among people who inject drugs in a high-burden setting.Nature communications · 2026Article
- The Potential Impact of Federal Funding Cuts on Access to Pre-Exposure Prophylaxis in Atlanta, Georgia: Geographic Modeling Study.JMIR public health and surveillance · 2026Article
- Evaluating Spatially Targeted HIV Interventions and Harm Reduction Services Among People Who Inject Drugs in a High-Burden Setting.medRxiv : the preprint server for health sciences · 2026Article
- A county-level HIV prevention gap index in the US Deep South using publicly available proxy indicators.Frontiers in public health · 2026Article
- Mapping of sex work hotspots to guide targeted HIV prevention: Evidence from eight Ukrainian cities.PloS one · 2026Article
- The cross-cultural adaptation and psychometric evaluation of the Chinese version of the stigma scale for caring for individuals with sexually transmitted infections (STISS)-student version: a translation and validation study.Frontiers in psychology · 2026Article
- Advancing Programme Science approaches to understand gaps in HIV prevention programme coverage for key populations in 12 Nigerian states: findings from the 2020 Integrated Biological and Behavioural Surveillance Survey.Journal of the International AIDS Society · 2024Article
- Use of unsupervised machine learning to characterise HIV predictors in sub-Saharan Africa.BMC infectious diseases · 2023Article
- Article
- Geospatial Analysis of Time to Human Immunodeficiency Virus (HIV) Diagnosis and Adult HIV Testing Coverage Highlights Areas for Intervention in the US Southeast.Open forum infectious diseases · 2023Article
- Assessing spatial patterns of HIV prevalence and interventions in semi-urban settings in South Africa. Implications for spatially targeted interventions.Geospatial health · 2022Article
- The role of high-risk geographies in the perpetuation of the HIV epidemic in rural South Africa: A spatial molecular epidemiology study.PLOS global public health · 2022Article
- Association of intimate partner violence and other risk factors with HIV infection among married women in India: evidence from National Family Health Survey 2015-16.BMC public health · 2021Article
- Use of machine learning techniques to identify HIV predictors for screening in sub-Saharan Africa.BMC medical research methodology · 2021Article
- Article
- Spatial analysis of factors associated with HIV infection in Malawi: indicators for effective prevention.BMC public health · 2020Article
- Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda.The lancet. HIV · 2020Article
- Tailored HIV programmes and universal health coverage.Bulletin of the World Health Organization · 2020Article
- Informing HIV Prevention Programs for Adolescent Girls and Young Women: A Modified Approach to Programmatic Mapping and Key Population Size Estimation.JMIR public health and surveillance · 2019Article
- Geographic correlates of primary and secondary syphilis among men who have sex with men in the United States.Annals of epidemiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewThe purpose of this study is to review and synthesize the recent literature on the use of geographical targeting to improve progression through HIV and sexually transmitted disease (STD) prevention and treatment continua in different populations. RECENT
findingsGeographical targeting can help identify obstacles to progression through prevention and treatment continua for each stage and in specific geographic locations. Macro-level geographical targeting can help maximize allocative efficiency, while micro-level targeting of hot spots increases effectiveness of interventions. Migration into and out of geographical areas of interest constitutes a challenge to geographical targeting in that stage-specific monitoring strategies tend to yield inaccurate results when people leave the area. Despite these issues, it is possible to identify failures in each stage of the continuum by specific spatial location such as census tracts and focus improvement efforts accordingly. SUMMARY: Vulnerabilities, risk behaviours and infections all cluster across age, race-ethnicity, socioeconomic status, key populations, risk networks and geographic space. Spatial concentration may be the most important in this context, as it allows prevention programmes to identify and reach target populations more easily. Geographical targeting can be employed at both macro and micro levels and in combination with targeting of key populations and high-risk networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.